|
|
||||||||
Ann Thorac Surg 2002;73:1691
© 2002 The Society of Thoracic Surgeons
a Onassis Cardiac Surgery Center, 356 Sygrou Ave, 176 74 Athens, Greece
e-mail: geconomo{at}otenet.gr
To the Editor
We read with interest the recent article by Ascione and associates [1]. Although we agree in principle with one-stage treatment of combined coronary and abdominal diseases, we have serious reservations regarding the surgical strategy followed. We refer to the adverse hemodynamic effects imposed on the myocardium by suprarenal aortic clamping (and unclamping) during abdominal aortic aneurysm (AAA) resection. It has been documented that this maneuver causes serious and adverse alterations in diastolic and systolic myocardial function [2, 3].
With that in mind, we devised a protocol in 11 patients with the dual pathological process. If the preoperative evaluation (angiographic, viability, and echocardiographic studies) suggests that optimal myocardial recovery can be expected, AAA resection followed the open heart surgical procedure (with or without cardiopulmonary bypass [CPB]). When CPB is used, the patient is weaned from CPB, half of the protamine sulfate is given, the aortic cannula remains in place, and AAA resection followsa "wean and resect" strategy.
On the other hand, if the immediate postoperative myocardial function is expected to be questionable or problematic (eg, bad targets, ischemic cardiomyopathy, or diastolic dysfunction from valvular heart disease), AAA resection is performed after the cardiac procedure but with the patient on CPB support"resect on CPB" strategy. The hemodynamic and metabolic effects of suprarenal aortic clamping and unclamping are nullified by the CPB support, and myocardial recovery was uneventful in the 5 patients in the "resect on CPB" group. We were impressed by the safety and efficacy provided by CPB support in 2 patients in whom a huge (>9 cm) or a difficult (no neck) AAA was resected. Transesophageal echocardiography was used in all patients. There were no deaths and no major morbidity in this small series during a follow-up ranging from 9 to 46 months.
References
Related Article
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |